Johnson & Johnson on their new single-dose Covid vaccine | A Second Opinion Podcast

Johnson & Johnson on their new single-dose Covid vaccine

Alex Gorsky, Johnson & Johnson Chairman & CEO on their new single-dose Covid vaccine and preparing for the next public health crisis

Alex Gorsky, Johnson & Johnson Chairman & CEO on their new single-dose Covid vaccine and preparing for the next public health crisis

On the podcast today, Senator Frist is joined by Alex Gorsky, Chairman and CEO of Johnson & Johnson – a 135-year-old company that is at the forefront of innovation in pharmaceuticals, medical devices and consumer health products.    It’s perhaps the only American business that has played a leading role responding to both the 1918 Spanish flu and today’s Covid-19 pandemic – and today is the largest and most admired drug company in the world.

Alex is a brilliant leader who brings us the latest on J&J’s newly authorized, game-changing Covid-19 vaccine, which in trials, “100% of the time … kept people out of the hospital, and we kept them from dying, with a single dose.”  He explains that, “We were able to deliver 3.9 million of these vaccines at launch … And we’re on a path to have 100 million doses delivered in the United States by June of this year, and have nearly a billion for the world by the end of 2021.”

Alex also shares his compelling insights into how J&J has stayed competitive, on top, cutting-edge and profitable for generations, and how this life-altering pandemic is changing health and science for years to come.

Listen now on Apple Podcasts, Spotify, Stitcher or YouTube.